PREVIOUS QUESTION:

 

NEXT QUESTION:

 

Is CBD safe?

ANSWER

CBD comes in many forms, from liquid drops and capsules you swallow, to vapes. But the FDA doesn't regulate most of those products. The only FDA-approved form of CBD oil is Epidiolex, a prescription drug that treats two types of epilepsy. So it's hard to be sure that other CBD products are what they say they are, even if the label looks "official."

SOURCES:

FDA: “FDA Approves First Drug Comprised of an Active Ingredient Derived From Marijuana to Treat Rare, Severe Forms of Epilepsy.”

Mayo Clinic: “Consumer Health: What Are the Benefits of CBD — And is it Safe to Use?” “Diabetic Neuropathy.”

Diabetes Care : “Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with Type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel group pilot study.”

Chemico-Biological Interactions : “Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion.”

Journal of Experimental Medicine : “Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.”

Molecular and Cellular Biochemistry : “Cannabidiol promotes browning in 3T3-L1 adipocytes.”

The American Journal of Pathology : “The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.”

Cambridge Quarterly of Healthcare Ethics : “The Flaws and Human Harms of Animal Experimentation.”

Autoimmunity : “Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.”

Harvard Health Publishing: “Cannabidiol (CBD) — what we know and what we don’t.”

CDC: “Diabetes.”

Reviewed by Michael Dansinger on October 31, 2019

SOURCES:

FDA: “FDA Approves First Drug Comprised of an Active Ingredient Derived From Marijuana to Treat Rare, Severe Forms of Epilepsy.”

Mayo Clinic: “Consumer Health: What Are the Benefits of CBD — And is it Safe to Use?” “Diabetic Neuropathy.”

Diabetes Care : “Efficacy and safety of cannabidiol and tetrahydrocannabivarin on glycemic and lipid parameters in patients with Type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel group pilot study.”

Chemico-Biological Interactions : “Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion.”

Journal of Experimental Medicine : “Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.”

Molecular and Cellular Biochemistry : “Cannabidiol promotes browning in 3T3-L1 adipocytes.”

The American Journal of Pathology : “The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications.”

Cambridge Quarterly of Healthcare Ethics : “The Flaws and Human Harms of Animal Experimentation.”

Autoimmunity : “Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.”

Harvard Health Publishing: “Cannabidiol (CBD) — what we know and what we don’t.”

CDC: “Diabetes.”

Reviewed by Michael Dansinger on October 31, 2019

NEXT QUESTION:

What is benfotiamine?

WAS THIS ANSWER HELPFUL

"ALEXA, ASK WEBMD"

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: